Synthesis of Spiropyrrolidines and Spiropyrrolizidines by Azomethine Ylide Cycloaddition of Baylis-Hillman Adducts Derived from N-Methyl Maleimide

Abstract

The stereoselective synthesis of a series of novel spiropyrrolidines and spiropyrrolizidines has been accomplished through an intermolecular 1,3-dipolar cycloaddition of an azomethine ylides with dipolarophiles derived from the Baylis-Hillman reaction of ­isatins with N-methyl maleimide.

Baylis-Hillman reaction - azomethine ylide cycloadditon - spiropyrrolidines - spiropyrrolizidines

References and Notes

1a Morita K. inventors; JP  6,803,364.  ; Chem. Abstr. 1968, 69, 58828s

1b Morita K. Suzuki Z. Hirose H. Bull. Chem. Soc. Jpn.  1968,  41:  2815 

1c Baylis AB, and Hillman MED. inventors; DE  2,155,113.  ; Chem. Abstr. 1972, 77, 34174q

1d Hillman MED, and Baylis AB. inventors; US  3,743,669. 

For reviews, see:

2a Drewes SE. Roo GHP. Tetrahedron  1988,  44:  4653 

2b Basavaiah D. Rao PD. Hyma RS. Tetrahedron  1996,  52:  8001 

2c Ciganek E. Org. React.  1997,  51:  201 

2d Langer P. Angew. Chem. Int. Ed.  2000,  39:  3049 

2e Basavaiah D. Rao AJ. Satyanarayana T. Chem. Rev.  2003,  103:  811 

3a Price KE. Broadwater SJ. Jung HM. McQuade DT. Org. Lett.  2005,  7:  147 

3b Aggarwal VK. Fulford SY. Lloyd-Jones GC. Angew. Chem. Int. Ed.  2005,  44:  1706 

3c Price KE. Broadwater SJ. Walker BJ. McQuade DT. J. Org. Chem.  2005,  70:  3980 

4a Santos LS. Pavam CH. Almeida WP. Coelho F. Eberlin MN. Angew. Chem. Int. Ed.  2004,  43:  4330 

4b Krafft ME. Haxell TFN. Seibert KA. Abboud KA. J. Am. Chem. Soc.  2006,  128:  4174 

5a Iwabuchi Y. Nakatani M. Yokoyama N. Hatakeyama S. J. Am. Chem. Soc.  1999,  121:  10219 

5b Yang K.-S. Lee W.-D. Pan J.-F. Chen K.-M. J. Org. Chem.  2003,  68:  915 

5c Imbriglio JE. Vasbinder MM. Miller SJ. Org. Lett.  2003,  5:  3741 

5d McDougal NT. Schaus SE. J. Am. Chem. Soc.  2003,  125:  12094 

5e Wang J. Li H. Yu X. Zu L. Wang W. Org. Lett.  2005,  7:  4293 

5f Xu J. Guan Y. Yang S. Ng Y. Peh G. Tan C.-H. Chem. Asian J.  2006,  1:  724 

5g Berkessel A. Roland K. Neudörfl JM. Org. Lett.  2006,  8:  4195 

5h Nakano A. Takahashi K. Ishihara J. Hatakeyama S. Org. Lett.  2006,  8:  5357 

6 da Silva JFM. Garden SJ. Pinto AC. J. Braz. Chem. Soc.  2001,  12:  273 

7 Garden SJ. Skakle JMS. Tetrahedron Lett.  2002,  43:  1969 

8a 1,3-Dipolar Cycloaddition Chemistry   Vol. 1 and 2:  Padwa A. Wiley; New York: 1984. 

8b Tsuge O. Kanemasa S. In Advances in Heterocyclic Chemistry   Vol. 45:  Katritzky AR. Academic Press; San Diego: 1989.  p.231-252  

8c Advances in Cycloaddition   Vol. 3:  Grigg R. Sridharan V. Curran DP. Jai Press; London: 1993.  p.161-180  

8d Nyerges M. Feges I. Toke L. Tetrahedron Lett.  2000,  41:  7951 

8e Dondas HA. Grigg R. MacLachlan WS. MacPherson DT. Markandu J. Sridharan V. Suganthan S. Tetrahedron Lett.  2000,  41:  967 

8f Grigg R. Thornton-Pett M. Yoganathan G. Tetrahedron  1999,  55:  1763 

8g Grigg R. Thornton-Pett M. Xu J. Xu L.-H. Tetrahedron  1999,  55:  13841 

8h Pearson WH. Clark RB. Tetrahedron Lett.  1997,  38:  7669 

8i Pearson WH. Mi Y. Tetrahedron Lett.  1997,  38:  5441 

8j Waldmann H. Blaser E. Jansen M. Letschert H.-P. Angew. Chem., Int. Ed. Engl.  1994,  33:  683 

9 Sebahar PR. Williams RM. J. Am. Chem. Soc.  2000,  122:  5666 

10a Pandey G. Banerjee P. Gadre SR. Chem. Rev.  2006,  106:  4484 

10b Coldham I. Hufton R. Chem. Rev.  2005,  105:  2765 

10c Nair V. Suja TD. Tetrahedron  2007,  63:  12247 

10d Chen X.-H. Wei Q. Luo S.-W. Xiao H. Gong L.-Z. J. Am. Chem. Soc.  2009,  131:  13819 

10e Kumar A. Gupta G. Srivastava S. J. Comb. Chem.  2010,  12:  458 

11a Kumar RR. Perumal S. Senthilkumar P. Yogeeswari P. Sriram D. Tetrahedron  2008,  64:  2962 

11b Kumar RR. Perumal S. Senthilkumar P. Yogeeswari P. Sriram D. Eur. J. Med. Chem.  2009,  3821 

11c Kumar RR. Rajesh SM. Perumal S. Banerjee D. Yogeeswari P. Sriram D. Eur. J. Med. Chem.  2010,  411 

11d Liu H. Dou G. Shi D. J. Comb. Chem.  2010,  12:  292 

12 Alkaloids Chemical and Biological Perspectives   Monlineux RJ. Pelletier SW. Wiley; New York: 1987.  Chap. 1.

13a Jossang A. Jossang P. Hadi HA. Sevenet T. Bodo B. J. Org. Chem.  1991,  56:  6527 

13b James MNG. Williams GJB. Can. J. Chem.  1972,  50:  2407 

13c Elderfield RC. Gilman RE. Phytochemistry  1972,  11:  339 

13d Cui CB. Kakeya H. Okada G. Onose R. Osada H. J. Antibiot.  1996,  49:  527 

14a Kozikowski AP. Acc. Chem. Res.  1984,  17:  410 

14b Howe RK. Shelton BR. J. Org. Chem.  1990,  55:  4603 

14c De Amici M. De Michelli C. Misani V. Tetrahedron  1990,  46:  1975 

14d Cohen VL, and Kleinmann EE. inventors; WO  24192.  ; Chem. Abstr. 1995, 123: 296610t

14e Carroll WA. Grieco PA. J. Am. Chem. Soc.  1993,  115:  1164 

14f Earley WG. Oh T. Overman LE. Tetrahedron Lett.  1988,  29:  3785 

14g Ban Y. Taga N. Oishi T. Chem. Pharm. Bull.  1976,  24:  736 

14h Ban Y. Seto M. Oishi T. Chem. Pharm. Bull.  1975,  23:  2605 

14i Ban Y. Taga N. Oishi T. Tetrahedron Lett.  1974,  15:  187 

14j Van Tamelen EE. Yardley JP. Miyano M. Hinshaw WB. J. Am. Chem. Soc.  1969,  91:  7333 

15 Ding K. Lu Y. Nikolovska-Coleska Z. Wang G. Qiu S. Shangary S. Gao W. Qin D. Stuckey J. Krajeswski K. Roler PP. Wang S. J. Med. Chem.  2006,  49:  3432 

16 Hilton ST. Ho TCT. Pljevalijcic G. Jones K. Org. Lett.  2000,  2:  2639 

17a Karthikeyan K. Perumal PT. Etti S. Shanmugam G. Tetrahedron  2007,  63:  10581 

17b Karthikeyan K. Seelan TV. Lalitha KG. Perumal PT. Bioorg. Med. Chem. Lett.  2009,  19:  3370 

17c Karthikeyan K. Kumar RS. Muralidharan D. Perumal PT. Tetrahedron Lett.  2009,  50:  7175 

17d Praveen C. Karthikeyan K. Perumal PT. Tetrahedron  2009,  65:  9244 

17e Ramchandiran K. Karthikeyan K. Muralidharan D. Perumal PT. Tetrahedron Lett.  2010,  51:  3006 

17f Karthikeyan K. Sivakumar PM. Doble M. Perumal PT. Eur. J. Med. Chem.  2010,  3446 

18a Karthikeyan K. Perumal PT. Synlett  2009,  2366 

18b Zulykama Y. Perumal PT. Aust. J. Chem.  2007,  60:  205 

18c Zulykama Y. Perumal PT. Tetrahedron Lett.  2009,  50:  3892 

18d Zulykama Y. Uma U. Devi PC. Perumal PT. Can. J. Chem.  2009,  87:  1682 

19

Experimental Procedure for the Synthesis of Baylis-Hillman Adducts 3a-g A mixture of isatin 1a-g (1.62 mmol), N-methyl maleimide (2, 1.35 mmol), and DABCO (30 mol%) was stirred at 80 ˚C under neat conditions. Completion of the reaction was evidenced by TLC analysis. The residue was dissolved in EtOAc (20 mL) and H₂O washed (2 × 20 mL). The EtOAc layer was dried over anhyd Na₂SO₄, and the solvent was removed under reduced pressure to obtain a crude product, which was purified by column chromatography with EtOAc-PE (2:8) as an eluent to obtain Baylis-Hillman adducts 3a-g.
Baylis-Hillman Adduct 3a Colorless solid; mp 148-150 ˚C. IR: 3368, 3115, 1722, 1610, 1488, 1380, 1162 cm^-¹. ^¹H NMR (500 MHz, CDCl₃): δ = 2.88 (s, 3 H), 3.25 (s, 3 H), 4.73 (br s, 1 H), 6.77 (s, 1 H), 6.91 (d, 1 H, J = 7.7 Hz), 7.09 (t, 1 H, J = 7.7 Hz), 7.28 (d, 1 H, J = 6.9 Hz), 7.38 (t, 1 H, J = 7.6 Hz). ^¹³C NMR (125 MHz, CDCl₃): δ = 23.8, 26.8, 74.6, 109.4, 123.8, 124.8, 127.5, 128.8, 131.2, 143.9, 147.4, 168.9, 169.5, 174.5. MS: m/z = 273 [M + H]⁺. Anal. Calcd for C₁₄H₁₂N₂O₄ (272.08): C, 61.76; H, 4.44; N, 10.29. Found: C, 61.84; H, 4.47; N, 10.16.

20

Crystallographic data of compound 3f in this letter have been deposited with the Cambridge Crystallographic Data Centre as supplemental publication No. CCDC-787472. Copies of the data can be obtained, free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: [phone] or email: [e-mail]].

21

Experimental Procedure for the Synthesis of Spiropyrrolidines 5a-e A mixture of isatin 1 (1 mmol), sarcosine (4, 1.5 mmol), and Baylis-Hillman adducts 3 (1 mmol) was refluxed in MeOH (10 mL). Completion of the reaction was evidenced by TLC analysis. The solvent was removed under vacuo, and the crude product was subjected to column chromatography using EtOAc-PE (2:8) as an eluent to afford pure spiropyrrolidines 5a-e.
3a′-(3-Hydroxy-1-methyl-2-oxoindolin-3-yl)-1,2′,5′-trimethyl-3′,3a′-dihydro-2′ H -spiro{indoline-3,1′-pyrrolo[3,4- c ]pyrrole}-2,4′,6′(5′ H ,6a′ H )-trione (5a)
Colorless solid; mp 258-260 ˚C. IR: 3361, 2963, 1699, 1612, 1471, 1373, 1124 cm^-¹. ^¹H NMR (500 MHz, CDCl₃): δ = 1.99 (s, 3 H), 2.65 (s, 3 H), 3.21 (s, 3 H), 3.24 (s, 3 H), 3.62 (d, 1 H, J = 11.5 Hz), 3.92 (s, 1 H), 4.32 (d, 1 H, J = 11.5 Hz), 5.81 (br s, 1 H), 6.77 (d, 1 H, J = 7.7 Hz), 6.82 (d, 1 H, J = 7.7 Hz), 6.89-6.93 (m, 2 H), 7.08-7.10 (m, 2 H), 7.26 (t, 1 H, J = 6.9 Hz), 7.38 (t, 1 H, J = 7.6 Hz). ^¹³C NMR (125 MHz, CDCl₃): δ = 25.1, 26.2, 26.4, 34.6, 53.2, 55.0, 63.4, 72.3, 74.3, 108.8, 108.9, 121.8, 123.3, 123.4, 123.9, 126.4, 126.9, 130.4, 130.7, 143.9, 144.1, 174.0, 175.4, 177.1, 177.6. MS: m/z = 461 [M + H]⁺. Anal. Calcd for C₂₅H₂₄N₄O₅ (460.17): C, 65.21; H, 5.25; N, 12.17. Found: C, 65.29; H, 5.23; N, 12.24.

22

Crystallographic data of compound 5c in this letter have been deposited with the Cambridge Crystallographic Data Centre as supplemental publication No. CCDC-787473. Copies of the data can be obtained, free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: [phone] or email: [e-mail]].

23

Experimental Procedure for the Synthesis of Spiropyrrolizidines 7a-e A mixture of isatin 1 (1 mmol), l-proline (6, 1.5 mmol), and Baylis-Hillman adducts 3 (1 mmol) was refluxed in MeOH (10 mL). Completion of the reaction was evidenced by TLC analysis. The solvent was removed under vacuo, and the crude product was subjected to column chromatography using EtOAc-PE (2:8) as an eluent to afford pure spiropyrrolizidines 7a-e. 8b′-(1-Ethyl-3-hydroxy-2-oxoindolin-3-yl)-1,2′-dimethyl-6′,7′,8′,8a′-tetrahydro-1′ H -spiro{indoline-3,4′-pyrrolo[3,4- a ]pyrrolizine}-1′,2,3′(2′ H ,3a′ H ,8b′ H )-trione (7b) Brown solid; mp 230-232 ˚C. IR: 3342, 2935, 1705, 1610, 1468, 1371, 1089 cm^-¹. ^¹H NMR (500 MHz, CDCl₃): δ = 1.31 (t, 3 H, J = 6.9 Hz), 1.72-1.79 (m, 1 H), 1.87-1.91 (m, 3 H), 2.14-2.18 (m, 1 H), 2.31-2.36 (m, 1 H), 2.70 (s, 3 H), 3.21 (s, 3 H), 3.63-3.69 (m, 1 H), 3.80-3.86 (m, 1 H), 4.16 (s, 1 H), 4.76 (t, 1 H, J = 6.9 Hz), 5.66 (br s, 1 H), 6.78 (d, 1 H, J = 7.7 Hz), 6.86 (t, 2 H, J = 8.4 Hz), 6.93 (t, 1 H, J = 7.7 Hz), 7.06 (t, 1 H, J = 6.9 Hz), 7.17 (d, 1 H, J = 6.9 Hz), 7.26 (t, 1 H, J = 7.7 Hz), 7.35 (t, 1 H, J = 7.7 Hz). ^¹³C NMR (125 MHz, CDCl₃): δ = 12.4, 24.6, 24.9, 25.8, 26.3, 35.0, 42.3, 58.5, 62.2, 65.0, 66.9, 75.0, 108.7, 108.8, 122.5, 122.9, 124.2, 124.3, 126.4, 127.6, 130.2, 130.5, 143.4, 143.7, 174.3, 175.0, 177.2. MS: m/z = 501 [M + H]⁺. Anal. Calcd for C₂₈H₂₈N₄O₅ (500.21): C, 67.19; H, 5.64; N, 11.19. Found: C, 67.42; H, 5.66; N, 11.40.